SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015325
Filing Date
2023-04-27
Accepted
2023-04-27 16:34:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A fusn-2023-proxy-naa.htm DEFA14A 25810
2 GRAPHIC img28929700_0.jpg GRAPHIC 623241
3 GRAPHIC img28929700_1.jpg GRAPHIC 579580
  Complete submission text file 0000950170-23-015325.txt   1683384
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39344 | Film No.: 23857691
SIC: 2836 Biological Products, (No Diagnostic Substances)